As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
Dont accept any other treatment
Red blood cell counts rising after beginning B12 injections is a clear sign that the treatment is effective
Is the B12 compromised
More severe side effects include: Advertisement It can be difficult to diagnose vitamin B12 deficiency because you may not have symptoms, or symptoms can be like other nutritional deficiencies
This pattern is not unique to tirzepatide but reflects the biology of obesity and metabolic adaptation
